A Phase 1/2 Study to Evaluate MEDI4736

Clinical trial NCT01693562 · COMPLETED

Trial details

NCT number: NCT01693562
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2012-09-05
Primary completion: 2020-02-28
Enrollment: 1022

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.